https://www.selleckchem.com/products/gsk-j1.html
For yellow fever vaccination, delay in campaigns leads to a potential disease burden rise of 1 death per 100,000 people per year until the campaigns are implemented. For meningococcal A vaccination, short-term disruptions in 2020 are unlikely to have a significant impact due to the persistence of direct and indirect benefits from past introductory campaigns of the 1- to 29-year-old population, bolstered by inclusion of the vaccine into the routine immunisation schedule accompanied by further catch-up campaigns. The impact of COVID-19
Tycka om
Kommentar
Dela med sig
